Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine
- 1 April 1997
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 154 (4) , 466-474
- https://doi.org/10.1176/ajp.154.4.466
Abstract
OBJECTIVE: The authors investigated whether primary negative symptoms of schizophrenia are enduring or treatment-responsive. METHODS: Previously, a double-blind, random-assignment trial of the nove...Keywords
This publication has 34 references indexed in Scilit:
- Olanzapine, a novel atypical antipsychotic, reversesd-amphetamine-induced inhibition of midbrain dopamine cellsPsychopharmacology, 1996
- A Longitudinal Study of Symptom Dimensions in SchizophreniaArchives of General Psychiatry, 1995
- Symptoms of SchizophreniaArchives of General Psychiatry, 1995
- A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patientsArchiv Fur Psychiatrie Und Nervenkrankheiten, 1995
- Structure and Course of Positive and Negative Symptoms in SchizophreniaArchives of General Psychiatry, 1995
- Statistical Models for Causal AnalysisPublished by Wiley ,1993
- A prospective study of clozapine in treatment-resistant schizophrenic patientsPsychopharmacology, 1989
- Predictors of response to clozapine therapyPsychopharmacology, 1989
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Negative v Positive SchizophreniaArchives of General Psychiatry, 1982